R

Renovaro Biosciences Inc
NASDAQ:RENB

Watchlist Manager
Renovaro Biosciences Inc
NASDAQ:RENB
Watchlist
Price: 1.266 USD
Market Cap: 29.3m USD

Operating Margin
Renovaro Biosciences Inc

0%
Current
0%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-19.4m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Renovaro Biosciences Inc
Glance View

Market Cap
29.3m USD
Industry
Biotechnology

Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 11 full-time employees. The company went IPO on 2014-11-18. The company is focused on developing allogeneic cell and gene therapies to promote stronger immune system responses for long-term or life-long cancer remission in cancers and to treat or cure infectious diseases, such as Human Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) infection. The Allogeneic Cell Therapy platform has a human immune system, which is designed to recognize the self and destroy otherness or non-self, such as bacteria, viruses and cancer cells. Its product candidates include ENOB-HV-01, which utilizes a cellular- and immunotherapy approach that could provide both preventative and therapeutic vaccines for HIV and ENOB-DC-11, which is a genetically modified allogeneic dendritic cell therapeutic vaccine as product for long-term remission of solid tumors. The company is also exploring ENOB-HV-21, a treatment for HIV with allogeneic natural killer and gamma delta t-cells.

RENB Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-19.4m
/
Revenue
0
What is the Operating Margin of Renovaro Biosciences Inc?

Based on Renovaro Biosciences Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top